Kit For Yttrium-90-Ibritumomab IV
- blood/bone marrow disorders (e.g., neutropenia, thrombocytopenia)
- recent/current infections
This drug may make you dizzy. Do not drive, use machinery, or do any activity that requires alertness until you are sure you can perform such activities safely. Limit alcoholic beverages.
Before having surgery, tell your doctor or dentist that you are using this medication.
Do not have immunizations/vaccinations without the consent of your doctor, and avoid contact with people who have recently received oral polio vaccine or flu vaccine inhaled through the nose.
Wash your hands well to prevent the spread of infections.
To lower your risk of getting cut, bruised, or injured, use caution with sharp objects like razors and nail cutters, and avoid activities such as contact sports.
Since this medication may harm an unborn baby, both men and women receiving this medication should use at least 2 reliable forms of birth control (e.g., condoms, birth control pills) during treatment with this medication and for 12 months afterwards. Consult with your doctor for more details.
This medication is not recommended for use during pregnancy. If you become pregnant or think you may be pregnant, tell your doctor immediately.
It is not known whether this drug passes into breast milk. Because of the possible risk to the infant, breast-feeding while using this drug is not recommended. Consult your doctor before breast-feeding.
Kit For Yttrium-90-Ibritumomab IV Medical Alert
Your condition can cause complications in a medical emergency. For information about enrolling in MedicAlert, call 1-800-854-1166 (USA) or 1-800-668-1507 (Canada).
Previous Section
